-
1
-
-
84874887247
-
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
-
Steingart KR, Sohn H, Schiller I, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014, 1.
-
(2014)
Cochrane Database Syst Rev
, pp. 1
-
-
Steingart, K.R.1
Sohn, H.2
Schiller, I.3
-
2
-
-
79960509329
-
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting
-
Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011, 184:132-140.
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 132-140
-
-
Theron, G.1
Peter, J.2
van Zyl-Smit, R.3
-
3
-
-
84907270362
-
Diagnostic delays and clinical decision-making with centralized Xpert MTB/RIF testing in Durban, South Africa
-
Published online August 12.
-
Cohen GM, Drain PK, Noubary F, Cloete C, Bassett IV Diagnostic delays and clinical decision-making with centralized Xpert MTB/RIF testing in Durban, South Africa. J Acquir Imm Defic Syndr 2014, Published online August 12. http://dx.doi.org/10.1097/QAI.0000000000000309.
-
(2014)
J Acquir Imm Defic Syndr
-
-
Cohen, G.M.1
Drain, P.K.2
Noubary, F.3
Cloete, C.4
Bassett, I.V.5
-
5
-
-
84885665977
-
Tuberculosis
-
Scully T Tuberculosis. Nature 2013, 502:S1-SS.
-
(2013)
Nature
, vol.502
, pp. S1-SS
-
-
Scully, T.1
-
6
-
-
84895071180
-
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
-
Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014, 383:424-435.
-
(2014)
Lancet
, vol.383
, pp. 424-435
-
-
Theron, G.1
Zijenah, L.2
Chanda, D.3
-
7
-
-
84901058039
-
Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?
-
Theron G, Peter J, Dowdy D, Langley I, Squire SB, Dheda K Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?. Lancet Infect Dis 2014, 14:527-532.
-
(2014)
Lancet Infect Dis
, vol.14
, pp. 527-532
-
-
Theron, G.1
Peter, J.2
Dowdy, D.3
Langley, I.4
Squire, S.B.5
Dheda, K.6
-
8
-
-
84863461477
-
Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
-
Theron G, Pooran A, Peter J, et al. Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?. Eur Respir J 2012, 40:161-168.
-
(2012)
Eur Respir J
, vol.40
, pp. 161-168
-
-
Theron, G.1
Pooran, A.2
Peter, J.3
-
9
-
-
84883524366
-
Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
-
Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J 2013, 42:708-720.
-
(2013)
Eur Respir J
, vol.42
, pp. 708-720
-
-
Pantoja, A.1
Fitzpatrick, C.2
Vassall, A.3
Weyer, K.4
Floyd, K.5
-
10
-
-
82455205785
-
Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis
-
Vassall A, van Kampen S, Sohn H, et al. Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 2011, 8:e1001120.
-
(2011)
PLoS Med
, vol.8
, pp. e1001120
-
-
Vassall, A.1
van Kampen, S.2
Sohn, H.3
-
11
-
-
84870266092
-
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
-
Menzies NA, Cohen T, Lin H-H, Murray M, Salomon JA Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med 2012, 9:e1001347.
-
(2012)
PLoS Med
, vol.9
, pp. e1001347
-
-
Menzies, N.A.1
Cohen, T.2
Lin, H.-H.3
Murray, M.4
Salomon, J.A.5
-
12
-
-
84907262438
-
Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
-
Langley I, Lin H-H, Egwaga S, et al. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Glob Health 2014, 2:e581-e591.
-
(2014)
Lancet Glob Health
, vol.2
, pp. e581-e591
-
-
Langley, I.1
Lin, H.-H.2
Egwaga, S.3
-
13
-
-
34250314931
-
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
-
Getahun H, Harrington M, O'Brien R, Nunn P Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007, 369:2042-2049.
-
(2007)
Lancet
, vol.369
, pp. 2042-2049
-
-
Getahun, H.1
Harrington, M.2
O'Brien, R.3
Nunn, P.4
-
14
-
-
84867133991
-
The impact of new tuberculosis diagnostics on transmission: why context matters
-
Lin H-H, Dowdy D, Dye C, Murray M, Cohen T The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ 2012, 90:739-747.
-
(2012)
Bull World Health Organ
, vol.90
, pp. 739-747
-
-
Lin, H.-H.1
Dowdy, D.2
Dye, C.3
Murray, M.4
Cohen, T.5
-
15
-
-
80055028625
-
Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm
-
Swai HF, Mugusi FM, Mbwambo JK Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm. BMC Res Notes 2011, 4:475.
-
(2011)
BMC Res Notes
, vol.4
, pp. 475
-
-
Swai, H.F.1
Mugusi, F.M.2
Mbwambo, J.K.3
-
16
-
-
84886470418
-
Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis
-
Walusimbi S, Bwanga F, De Costa A, Haile M, Joloba M, Hoffner S Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis 2013, 13:507.
-
(2013)
BMC Infect Dis
, vol.13
, pp. 507
-
-
Walusimbi, S.1
Bwanga, F.2
De Costa, A.3
Haile, M.4
Joloba, M.5
Hoffner, S.6
-
17
-
-
84883607703
-
Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult tuberculosis suspects in Uganda
-
Nakiyingi L, Bwanika JM, Kirenga B, et al. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult tuberculosis suspects in Uganda. PLOS One 2013, 8:e74023.
-
(2013)
PLOS One
, vol.8
, pp. e74023
-
-
Nakiyingi, L.1
Bwanika, J.M.2
Kirenga, B.3
-
18
-
-
84871303261
-
Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting
-
Huerga H, Varaine F, Okwaro E, et al. Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting. PLoS One 2012, 7:e51336.
-
(2012)
PLoS One
, vol.7
, pp. e51336
-
-
Huerga, H.1
Varaine, F.2
Okwaro, E.3
-
19
-
-
84868702003
-
Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa-a systematic review
-
Barter D, Agboola S, Murray M, Barnighausen T Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa-a systematic review. BMC Public Health 2012, 12:980.
-
(2012)
BMC Public Health
, vol.12
, pp. 980
-
-
Barter, D.1
Agboola, S.2
Murray, M.3
Barnighausen, T.4
|